Prescription Opiates

The INCB releases its annual drug report and so does the US State Department, DC moves toward marijuana decriminalization and so does New Hampshire, the Georgia House approves a CBD medical marijuana bill and so does the Utah House, and more.

A Europe-wide marijuana legalization initiative campaign is underway, a Republican legalization groups will hold its first meeting in Texas, there's still a California legalization initiative trying to make the ballot this year, state legislatures deal reflexively with familiar drug issues, and more.

Marijuana politics continues to dominate the drug news, but meanwhile, the FDA has banned its first tobacco product, the DEA wants you to snitch out pain pill abusers, Delaware makes diverting a pain pill a felony -- and speaking of Delaware and diversion, someone has been diverting Oxycontin from the medical examiner's office, and more.

A bill has been filed to stop forcing the drug czar to oppose marijuana legalization, CBD medical marijuana bills continue to get attention, and there are big doings south of the border, and more.

Overdose prevention is big news today as the drug czar chimes in in favor, more than a dozen congressmen call on Obama to re- or de-schedule marijuana, the Italian Supreme Court undoes a bad drug law, and more.

More cops with pain pill problems, one who seemed like he was headed to (or from) a party, and a Texas parole officer gets too tight with a parolee.

Busy, busy. Cops on pain pills, crooked drug task force commanders, and more.

The Denver city council votes today on where you can smoke pot, a Tennessee bill equates meth-making with child abuse, there's dissent on drug policy at the UN, India fights a drug menace, and more.

Hmmm, on the same day the DEA warns that "marijuana availability seems to be on the increase," hundreds of people apply for licenses to sell pot in Washington state. Times are changing, and somebody needs to let the DEA know. And there's more news, too.

In its war against the diversion of prescription pills, the DEA has targeted doctors, pharmacies, wholesale drug suppliers, and now package delivery services. UPS has buckled, but FedEx is resisting.